“I hope our nutrition-based approach to cancer management can change lives around the world.”
Dr. Wang is a founder of Filtricine and is an inventor of Targeted Nutrients Deprivation. He is an authority on novel therapeutics and personalized medicine with a specialty in cancer and infectious disease. His work has resulted in three antiviral drugs in Phase II clinical trials and one vaccine candidate in preclinical study. He has published over 30 peer-reviewed papers and has filed 3 patent applications with Stanford University. Dr. Wang holds a medical degree from Tianjin Medical University in China and holds a PhD from Kagoshima University in Japan. He completed post-doctoral training at Japan Science and Technology Agency and with Dr. Yung-Chi Cheng at Yale University.